24Business
Galderma’s Nemluvio ® (Nemolizumab) has approved in the European Union for moderate domestic atopic dermatitis and prurigo nodularis
Galderma’s nonluvio ® (Nemolizumab) has approved in the European Union for moderate Do-the-Teska atopic dermatitis and Prurigo nodularis
Source link
